Nailfold capillaroscopy abnormalities are associated with the presence of anti-endothelial cell antibodies in Sjogren's syndrome SIR, Primary SS is often associated with vascular features such as RP, in 10-30% of the cases and vasculitis [1] . In SS microvascular abnormalities, assessed by nailfold capillaroscopy (NC), range from non-specific to more specific or scleroderma-type findings [2] [3] [4] . Patients with RP seem to have a higher frequency of NC abnormalities with respect to non-RP patients and a sclerodermatype NC pattern is associated with the presence of ACAs [2] . A higher deletion score on NC microscopy has been described in those SS patients with systemic manifestations and RP [3] . Avascularity has been recently confirmed to be associated with a reduction of the blood flow [4] . Until now no association has been described in SS between NC findings and serological parameters of endothelial damage, including anti-endothelial cell antibodies (AECAs), although these autoantibodies, claimed for a possible pathogenetic role in autoimmune diseases, have been detected in 25-30% of SS and seem to be more frequent in those patients presenting RP [5] . We investigated the microvascular involvement in a group of 66 consecutive primary SS patients, diagnosed according to the American-European Criteria [6] [65 females, 1 male; mean age 54.2 years (range 26-76 years); mean disease duration 108.8 months (range 6-372 months)], looking for any NC abnormalities and for AECAs. Patients gave their informed consent and underwent a careful clinical assessment. The study was approved by the local ethics committee.
Each patient performed NC, according to the standard method [7] . The following morphological parameters were considered: number of capillaries per square millimetre, alterations of the capillary length, morphology (tortuous, ramified/bushy capillaries) and distribution; presence of ectasic loops, haemorrhages and flux abnormalities [7] . A semi-quantitative rating scale was adopted to score these changes, according to previous studies [8] : score 0 ¼ no changes; 1 ¼ few ¼ less than 4 alterations; 2 ¼ some ¼ between 4 and 6 alterations; 3 ¼ frequent ¼ more than 6 alterations per linear millimetre. The mean score for each subject was obtained analysing all fingers.
A full laboratory investigation included ESR, CRP, full blood count, ANA detection by indirect IF (Binding Site). Anti-SSA/Ro and anti-SSB/La antibodies were measured using an ELISA (DIAMEDIX, Miami, FL, USA). AECA serum levels were also measured. Briefly, human umbilical-vein endothelial cells were isolated by collagenase perfusion and were cultured in M199 medium (Sigma Chemical Co., St Louis, MO, USA).
Rheumatology key message
This proposed coding system can be used for all current and future biologics. These cells were used to detect AECA of IgG isotype by means of a cyto-ELISA as previously described [9] . Optical density (OD) was read at 405 nm wavelength and AECAs were expressed as a binding index (BI). AECAs were considered positive when the BI was higher than the cut-off value (mean þ 2 S.D. of 66 healthy controls) corresponding to 50% of a positive reference serum from an SLE patient. Each serum sample was tested in duplicate.
The statistical analysis was performed analysing categorical variables by 2 -test or Fisher's exact test and differences between the means were determined using Mann-Whitney test for unpaired samples. P-values < 0.05 were considered statistically significant. Twenty-six (39.4%) of the 66 SS patients presented RP, whereas an NC score 51 was found in 33 cases (50%), ANAs were found in 55 patients (83.3%), anti-SSA/Ro antibodies in 47 (71.2%) and anti-SSB/La in 35 (53%) subjects. Sixteen (24.2%) patients had AECA. RP was present in 8 (50%) AECA-positive patients and in 17 (34%) patients without these autoantibodies. The presence of ANA inversely correlated with the presence of AECA in our patients (56 vs 92%) (P < 0.003). An NC score of 51 was found in 13 (81.2%) AECA-positive patients (Fig. 1) , with respect to 20 (40%) AECA-negative patients (P < 0.008). No association was found concerning the other clinical, capillaroscopic or laboratory features (Table 1) .
Even though a peculiar NC pattern has not been characterized to date in SS patients (2-4), our findings show that an NC score 51 is detectable in 50% of the cases and is more frequent in AECA-positive patients with respect to those without these autoantibodies (P < 0.008). Although not significant, this group of patients also had a more frequent RP with respect to those without AECAs (50 vs 34%), as shown in previous studies, meaning that they may act with a mediated mechanism resulting in an increased vascular reactivity [5] . They also seemed to lack ANA with respect to AECA-negative patients, thus confirming a non-specific B-cell polyclonal activation in SS, where different antigenic targets may differently stimulate the autoantibody production. The detection of AECAs seems to be independent of the presence of antibodies with unrelated specificities, such as ANAs [10] .
A high prevalence of AECAs has been frequently associated with the presence of vascular lesions and with disease activity in autoimmune diseases. However, it is difficult to define the role of SS in the occurrence of AECAs, whose endothelial antigenic targets are still unknown. The pathogenetic role of AECAs in the development of vascular injury remains controversial.
We know that NC is a useful tool for the assessment of microvascular involvement in many autoimmune diseases and it seems to be able to show early abnormalities [8] . The interesting association of these NC findings with the presence of AECAs suggests that these autoantibodies are involved in the determinism of the endothelial damage in SS. The contemporary presence of AECAs and more frequent NC abnormalities led us to sustain the hypothesis that these two parameters may help in evaluating the expression of vasculopathy in SS. 
